Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | AMGN | VRTX | GILD | BMY |
| Company | Acceleron Pharma | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 179.85 | 262.11 | 408.00 | 90.30 | 55.68 |
| High | 179.85 | 267.40 | 411.14 | 90.37 | 55.79 |
| Low | 177.06 | 261.28 | 397.25 | 89.02 | 54.81 |
| Last | 178.75 | 267.10 | 411.58 | 90.08 | 55.24 |
| Change | -0.93 | +4.87 | +2.02 | +0.20 | -0.59 |
| % Change | -0.52% | +1.86% | +0.49% | +0.22% | -1.06% |
| Volume | 7,884,200 | 1,141,100 | 674,975 | 2,090,354 | 2,890,810 |
| 20-Day Average Volume | 1,302,050 | 3,518,456 | 1,975,313 | 6,152,772 | 11,421,762 |
| Previous Close | 179.68 | 262.23 | 409.56 | 89.88 | 55.83 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 263.46 | 419.86 | 91.89 | 56.73 |
| 20-Day Raw Stochastic | 84.01% | 59.76% | 33.68% | 23.33% | 9.24% |
| 20-Day Relative Strength | 70.12% | 42.67% | 39.09% | 46.38% | 43.71% |
| Weighted Alpha | +57.78 | -16.64 | -10.82 | +12.12 | +14.31 |
| Today's Opinion | 100% Buy | 88% Sell | 88% Sell | 56% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 100% Sell | 88% Sell | 56% Buy | 40% Buy |
| Last Month's Opinion | 88% Buy | 72% Sell | 8% Sell | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | +2.13% since 01/03/25 | +0.78% since 01/03/25 | -1.58% since 01/03/25 | -2.50% since 01/03/25 |
| Low | 173.17 on 11/16/21 | 257.05 on 01/06/25 | 397.44 on 01/13/25 | 88.57 on 01/10/25 | 54.81 on 01/13/25 |
| High | 179.94 on 11/17/21 | 267.40 on 01/13/25 | 413.52 on 01/10/25 | 91.53 on 01/06/25 | 57.67 on 01/07/25 |
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | -1.42% since 12/13/24 | -11.52% since 12/13/24 | -2.06% since 12/13/24 | -1.12% since 12/13/24 |
| Low | 172.25 on 10/20/21 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 88.57 on 01/10/25 | 54.81 on 01/13/25 |
| High | 179.94 on 11/17/21 | 272.69 on 12/16/24 | 474.18 on 12/17/24 | 94.55 on 12/26/24 | 58.54 on 12/18/24 |
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | -18.75% since 10/11/24 | -14.82% since 10/11/24 | +5.90% since 10/11/24 | +5.66% since 10/11/24 |
| Low | 120.20 on 08/20/21 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 84.34 on 10/14/24 | 51.31 on 10/15/24 |
| High | 189.99 on 09/29/21 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | -19.36% since 07/12/24 | -16.05% since 07/12/24 | +28.59% since 07/12/24 | +36.32% since 07/12/24 |
| Low | 113.49 on 07/15/21 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 70.21 on 07/15/24 | 39.92 on 07/15/24 |
| High | 189.99 on 09/29/21 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 140,957,296 | 105,473,568 | 112,014,384 | 113,233,128 |
| Shares Outstanding, K | 61,156 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 92,520,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -166,030,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 34,200,000 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -70,470,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 0.13 | 0.56 | 0.40 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/04/21 | 02/04/25 | 02/03/25 | 02/11/25 | 02/06/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 12/13/24 | 0.620 on 01/03/25 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 12/13/24 | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.75 | 0.00 | 20.12 | 48.56 |